These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11078417)

  • 21. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
    Bianciotti LG; de Bold AJ
    Cardiovasc Res; 2001 Mar; 49(4):808-16. PubMed ID: 11230980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
    Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
    Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.
    Cao Z; Cooper ME; Wu LL; Cox AJ; Jandeleit-Dahm K; Kelly DJ; Gilbert RE
    Hypertension; 2000 Oct; 36(4):561-8. PubMed ID: 11040236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved recovery following posttransplant acute renal failure in rat renal isografts with an oral endothelin-A receptor antagonist.
    Braun C; Vetter S; Conzelmann T; Schaub M; Kirchengast M; van der Woude FJ; Rohmeiss P
    Exp Nephrol; 2000; 8(4-5):283-90. PubMed ID: 10940728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.
    Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Yard B; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P
    Transplantation; 1999 Sep; 68(6):739-46. PubMed ID: 10515373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy.
    Cullen JP; Bell D; Kelso EJ; McDermott BJ
    Eur J Pharmacol; 2001 Apr; 417(3):157-68. PubMed ID: 11334846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
    Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
    Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased ET-1 and reduced ET(B) receptor expression in uremic hypertensive rats.
    D'Amours M; Chbinou N; Beaudoin J; Lebel M; Larivière R
    Clin Exp Hypertens; 2010 Jan; 32(1):61-9. PubMed ID: 20144075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of endothelin receptor antagonism and angiotensin-converting enzyme inhibition on cardiac and renal remodeling in the rat.
    Willette RN; Minehart H; Ellison J; Simons T; Short B; Pullen M; Ohlstein EH; Nambi P
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S277-83. PubMed ID: 9595459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
    Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of endothelin receptor antagonists on the progression of diabetic nephropathy.
    Hocher B; Schwarz A; Reinbacher D; Jacobi J; Lun A; Priem F; Bauer C; Neumayer HH; Raschack M
    Nephron; 2001 Feb; 87(2):161-9. PubMed ID: 11244312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
    Magga J; Vuolteenaho O; Marttila M; Ruskoaho H
    Circulation; 1997 Nov; 96(9):3053-62. PubMed ID: 9386175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia.
    Lin CY; Hsu YJ; Hsu SC; Chen Y; Lee HS; Lin SH; Huang SM; Tsai CS; Shih CC
    J Mol Cell Cardiol; 2015 Aug; 85():249-61. PubMed ID: 26093151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
    Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
    J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
    Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I
    Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.
    Hocher B; Kalk P; Slowinski T; Godes M; Mach A; Herzfeld S; Wiesner D; Arck PC; Neumayer HH; Nafz B
    J Am Soc Nephrol; 2003 Feb; 14(2):367-76. PubMed ID: 12538737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between eicosanoids and endothelin-1 in the pathogenesis of erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME; Moreau C; Larivière R; Lebel M
    J Cardiovasc Pharmacol; 2003 Mar; 41(3):388-95. PubMed ID: 12605017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic administration of an endothelin-A receptor antagonist after acute ischemic renal failure dose-dependently improves recovery of renal function.
    Knoll T; Schult S; Birck R; Braun C; Michel MS; Bross S; Juenemann KP; Kirchengast M; Rohmeiss P
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):483-8. PubMed ID: 11300661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
    Circulation; 2005 Jan; 111(3):302-9. PubMed ID: 15642760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.